Clinical Trial Update: Apixaban in Subjects With Peritoneal Dialysis [Phase 1]

View source ↗

Summary

Phase 1 study evaluating apixaban in subjects with chronic kidney disease on peritoneal dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Peritoneal Dialysis

Drugs mentioned

• Eliquis (apixaban) (apixaban)

Snippet

Sponsor: University Hospital, Caen | Conditions: Chronic Renal Insufficiency, Peritoneal Dialysis | Phase 1 | Status: COMPLETED